Chemical construction and structural permutation of potent cytotoxin polytheonamide B: discovery of artificial peptides with distinct functions.
Identifieur interne : 000A32 ( Ncbi/Merge ); précédent : 000A31; suivant : 000A33Chemical construction and structural permutation of potent cytotoxin polytheonamide B: discovery of artificial peptides with distinct functions.
Auteurs : Hiroaki Itoh [Japon] ; Masayuki InoueSource :
- Accounts of chemical research [ 1520-4898 ] ; 2013.
Descripteurs français
- KwdFr :
- Cytotoxines (), Cytotoxines (pharmacologie), Cytotoxines (synthèse chimique), Découverte de médicament (), Mutation ponctuelle, Peptidomimétiques (), Peptidomimétiques (pharmacologie), Peptidomimétiques (synthèse chimique), Protéines (), Protéines (génétique), Protéines (métabolisme), Protéines (synthèse chimique), Protéines et peptides de signalisation intracellulaire.
- MESH :
- génétique : Protéines.
- métabolisme : Protéines.
- pharmacologie : Cytotoxines, Peptidomimétiques.
- synthèse chimique : Cytotoxines, Peptidomimétiques, Protéines.
- Cytotoxines, Découverte de médicament, Mutation ponctuelle, Peptidomimétiques, Protéines, Protéines et peptides de signalisation intracellulaire.
English descriptors
- KwdEn :
- Cytotoxins (chemical synthesis), Cytotoxins (chemistry), Cytotoxins (pharmacology), Drug Discovery (methods), Intracellular Signaling Peptides and Proteins, Peptidomimetics (chemical synthesis), Peptidomimetics (chemistry), Peptidomimetics (pharmacology), Point Mutation, Proteins (chemical synthesis), Proteins (chemistry), Proteins (genetics), Proteins (metabolism).
- MESH :
- chemical , chemical synthesis : Cytotoxins, Peptidomimetics, Proteins.
- chemical , chemistry : Cytotoxins, Peptidomimetics, Proteins.
- chemical , genetics : Proteins.
- chemical , metabolism : Proteins.
- chemical , pharmacology : Cytotoxins, Peptidomimetics.
- methods : Drug Discovery.
- chemical : Intracellular Signaling Peptides and Proteins, Point Mutation.
Abstract
Polytheonamide B (1), isolated from the marine sponge Theonella swinhoei, is a posttranslationally modified ribosomal peptide (MW 5030 Da) that displays extraordinary cytotoxicity. Among its 48 amino acid residues, this peptide includes a variety D- and L-amino acids that do not occur in proteins, and the chiralities of these amino acids alternate in sequence. These structural features induce the formation of a stable β6.3-helix, giving rise to a tubular structure of over 4 nm in length. In the biological setting, this fold is believed to transport cations across the lipid bilayer through a pore, thereby acting as an ion channel. In this Account, we discuss the construction and structural permutations of this potent cytotoxin. First we describe the 161-step chemical construction of this unusual peptide 1. By developing a synthetic route to 1, we established the chemical basis for subsequent SAR studies to pinpoint the proteinogenic and nonproteinogenic building blocks within the molecule that confer its toxicity and channel function. Using fully synthetic 1, we generated seven analogues with point mutations, and studies of their activity revealed the importance of the N-terminal moiety. Next, we simplified the structure of 1 by substituting six amino acid residues of 1 to design a more synthetically accessible analogue 9. This dansylated polytheonamide mimic 9 was synthesized in 127 total steps, and we evaluated its function to show that it can emulate the toxic and ion channel activities of 1 despite its multiple structural modifications. Finally, we applied a highly automated synthetic route to 48-mer 9 to generate 13 substructures of 27-39-mers. The 37-mer 12 exhibited nanomolar level toxicity through a potentially distinct mode of action from 1 and 9. The SAR studies of polytheonamide B and the 21 artificial analogues have deepened our understanding of the precise structural requirements for the biological functions of 1. They have also led to the discovery of artificial molecules with various toxicities and channel functions. These achievements demonstrate the benefits of total synthesis and the importance of efficient construction of complex molecules. The knowledge accumulated through these studies will be useful for the rational design of new tailor-made channel peptides and cytotoxic molecules with desired functions.
DOI: 10.1021/ar300315p
PubMed: 23488446
Links toward previous steps (curation, corpus...)
- to stream PubMed, to step Corpus: 001D08
- to stream PubMed, to step Curation: 001D08
- to stream PubMed, to step Checkpoint: 001B89
Links to Exploration step
pubmed:23488446Le document en format XML
<record><TEI><teiHeader><fileDesc><titleStmt><title xml:lang="en">Chemical construction and structural permutation of potent cytotoxin polytheonamide B: discovery of artificial peptides with distinct functions.</title>
<author><name sortKey="Itoh, Hiroaki" sort="Itoh, Hiroaki" uniqKey="Itoh H" first="Hiroaki" last="Itoh">Hiroaki Itoh</name>
<affiliation wicri:level="4"><nlm:affiliation>Graduate School of Pharmaceutical Sciences, The University of Tokyo, Hongo, Bunkyo-ku, Tokyo 113-0033, Japan.</nlm:affiliation>
<country xml:lang="fr">Japon</country>
<wicri:regionArea>Graduate School of Pharmaceutical Sciences, The University of Tokyo, Hongo, Bunkyo-ku, Tokyo 113-0033</wicri:regionArea>
<placeName><settlement type="city">Tokyo</settlement>
<region type="région">Région de Kantō</region>
</placeName>
<orgName type="university">Université de Tokyo</orgName>
<placeName><settlement type="city">Tokyo</settlement>
<region type="province">Région de Kantō</region>
</placeName>
</affiliation>
</author>
<author><name sortKey="Inoue, Masayuki" sort="Inoue, Masayuki" uniqKey="Inoue M" first="Masayuki" last="Inoue">Masayuki Inoue</name>
</author>
</titleStmt>
<publicationStmt><idno type="wicri:source">PubMed</idno>
<date when="2013">2013</date>
<idno type="RBID">pubmed:23488446</idno>
<idno type="pmid">23488446</idno>
<idno type="doi">10.1021/ar300315p</idno>
<idno type="wicri:Area/PubMed/Corpus">001D08</idno>
<idno type="wicri:explorRef" wicri:stream="PubMed" wicri:step="Corpus" wicri:corpus="PubMed">001D08</idno>
<idno type="wicri:Area/PubMed/Curation">001D08</idno>
<idno type="wicri:explorRef" wicri:stream="PubMed" wicri:step="Curation">001D08</idno>
<idno type="wicri:Area/PubMed/Checkpoint">001B89</idno>
<idno type="wicri:explorRef" wicri:stream="Checkpoint" wicri:step="PubMed">001B89</idno>
<idno type="wicri:Area/Ncbi/Merge">000A32</idno>
</publicationStmt>
<sourceDesc><biblStruct><analytic><title xml:lang="en">Chemical construction and structural permutation of potent cytotoxin polytheonamide B: discovery of artificial peptides with distinct functions.</title>
<author><name sortKey="Itoh, Hiroaki" sort="Itoh, Hiroaki" uniqKey="Itoh H" first="Hiroaki" last="Itoh">Hiroaki Itoh</name>
<affiliation wicri:level="4"><nlm:affiliation>Graduate School of Pharmaceutical Sciences, The University of Tokyo, Hongo, Bunkyo-ku, Tokyo 113-0033, Japan.</nlm:affiliation>
<country xml:lang="fr">Japon</country>
<wicri:regionArea>Graduate School of Pharmaceutical Sciences, The University of Tokyo, Hongo, Bunkyo-ku, Tokyo 113-0033</wicri:regionArea>
<placeName><settlement type="city">Tokyo</settlement>
<region type="région">Région de Kantō</region>
</placeName>
<orgName type="university">Université de Tokyo</orgName>
<placeName><settlement type="city">Tokyo</settlement>
<region type="province">Région de Kantō</region>
</placeName>
</affiliation>
</author>
<author><name sortKey="Inoue, Masayuki" sort="Inoue, Masayuki" uniqKey="Inoue M" first="Masayuki" last="Inoue">Masayuki Inoue</name>
</author>
</analytic>
<series><title level="j">Accounts of chemical research</title>
<idno type="eISSN">1520-4898</idno>
<imprint><date when="2013" type="published">2013</date>
</imprint>
</series>
</biblStruct>
</sourceDesc>
</fileDesc>
<profileDesc><textClass><keywords scheme="KwdEn" xml:lang="en"><term>Cytotoxins (chemical synthesis)</term>
<term>Cytotoxins (chemistry)</term>
<term>Cytotoxins (pharmacology)</term>
<term>Drug Discovery (methods)</term>
<term>Intracellular Signaling Peptides and Proteins</term>
<term>Peptidomimetics (chemical synthesis)</term>
<term>Peptidomimetics (chemistry)</term>
<term>Peptidomimetics (pharmacology)</term>
<term>Point Mutation</term>
<term>Proteins (chemical synthesis)</term>
<term>Proteins (chemistry)</term>
<term>Proteins (genetics)</term>
<term>Proteins (metabolism)</term>
</keywords>
<keywords scheme="KwdFr" xml:lang="fr"><term>Cytotoxines ()</term>
<term>Cytotoxines (pharmacologie)</term>
<term>Cytotoxines (synthèse chimique)</term>
<term>Découverte de médicament ()</term>
<term>Mutation ponctuelle</term>
<term>Peptidomimétiques ()</term>
<term>Peptidomimétiques (pharmacologie)</term>
<term>Peptidomimétiques (synthèse chimique)</term>
<term>Protéines ()</term>
<term>Protéines (génétique)</term>
<term>Protéines (métabolisme)</term>
<term>Protéines (synthèse chimique)</term>
<term>Protéines et peptides de signalisation intracellulaire</term>
</keywords>
<keywords scheme="MESH" type="chemical" qualifier="chemical synthesis" xml:lang="en"><term>Cytotoxins</term>
<term>Peptidomimetics</term>
<term>Proteins</term>
</keywords>
<keywords scheme="MESH" type="chemical" qualifier="chemistry" xml:lang="en"><term>Cytotoxins</term>
<term>Peptidomimetics</term>
<term>Proteins</term>
</keywords>
<keywords scheme="MESH" type="chemical" qualifier="genetics" xml:lang="en"><term>Proteins</term>
</keywords>
<keywords scheme="MESH" type="chemical" qualifier="metabolism" xml:lang="en"><term>Proteins</term>
</keywords>
<keywords scheme="MESH" type="chemical" qualifier="pharmacology" xml:lang="en"><term>Cytotoxins</term>
<term>Peptidomimetics</term>
</keywords>
<keywords scheme="MESH" qualifier="génétique" xml:lang="fr"><term>Protéines</term>
</keywords>
<keywords scheme="MESH" qualifier="methods" xml:lang="en"><term>Drug Discovery</term>
</keywords>
<keywords scheme="MESH" qualifier="métabolisme" xml:lang="fr"><term>Protéines</term>
</keywords>
<keywords scheme="MESH" qualifier="pharmacologie" xml:lang="fr"><term>Cytotoxines</term>
<term>Peptidomimétiques</term>
</keywords>
<keywords scheme="MESH" qualifier="synthèse chimique" xml:lang="fr"><term>Cytotoxines</term>
<term>Peptidomimétiques</term>
<term>Protéines</term>
</keywords>
<keywords scheme="MESH" type="chemical" xml:lang="en"><term>Intracellular Signaling Peptides and Proteins</term>
<term>Point Mutation</term>
</keywords>
<keywords scheme="MESH" xml:lang="fr"><term>Cytotoxines</term>
<term>Découverte de médicament</term>
<term>Mutation ponctuelle</term>
<term>Peptidomimétiques</term>
<term>Protéines</term>
<term>Protéines et peptides de signalisation intracellulaire</term>
</keywords>
</textClass>
</profileDesc>
</teiHeader>
<front><div type="abstract" xml:lang="en">Polytheonamide B (1), isolated from the marine sponge Theonella swinhoei, is a posttranslationally modified ribosomal peptide (MW 5030 Da) that displays extraordinary cytotoxicity. Among its 48 amino acid residues, this peptide includes a variety D- and L-amino acids that do not occur in proteins, and the chiralities of these amino acids alternate in sequence. These structural features induce the formation of a stable β6.3-helix, giving rise to a tubular structure of over 4 nm in length. In the biological setting, this fold is believed to transport cations across the lipid bilayer through a pore, thereby acting as an ion channel. In this Account, we discuss the construction and structural permutations of this potent cytotoxin. First we describe the 161-step chemical construction of this unusual peptide 1. By developing a synthetic route to 1, we established the chemical basis for subsequent SAR studies to pinpoint the proteinogenic and nonproteinogenic building blocks within the molecule that confer its toxicity and channel function. Using fully synthetic 1, we generated seven analogues with point mutations, and studies of their activity revealed the importance of the N-terminal moiety. Next, we simplified the structure of 1 by substituting six amino acid residues of 1 to design a more synthetically accessible analogue 9. This dansylated polytheonamide mimic 9 was synthesized in 127 total steps, and we evaluated its function to show that it can emulate the toxic and ion channel activities of 1 despite its multiple structural modifications. Finally, we applied a highly automated synthetic route to 48-mer 9 to generate 13 substructures of 27-39-mers. The 37-mer 12 exhibited nanomolar level toxicity through a potentially distinct mode of action from 1 and 9. The SAR studies of polytheonamide B and the 21 artificial analogues have deepened our understanding of the precise structural requirements for the biological functions of 1. They have also led to the discovery of artificial molecules with various toxicities and channel functions. These achievements demonstrate the benefits of total synthesis and the importance of efficient construction of complex molecules. The knowledge accumulated through these studies will be useful for the rational design of new tailor-made channel peptides and cytotoxic molecules with desired functions.</div>
</front>
</TEI>
<pubmed><MedlineCitation Status="MEDLINE" Owner="NLM"><PMID Version="1">23488446</PMID>
<DateCompleted><Year>2014</Year>
<Month>01</Month>
<Day>27</Day>
</DateCompleted>
<DateRevised><Year>2019</Year>
<Month>12</Month>
<Day>10</Day>
</DateRevised>
<Article PubModel="Print-Electronic"><Journal><ISSN IssnType="Electronic">1520-4898</ISSN>
<JournalIssue CitedMedium="Internet"><Volume>46</Volume>
<Issue>7</Issue>
<PubDate><Year>2013</Year>
<Month>Jul</Month>
<Day>16</Day>
</PubDate>
</JournalIssue>
<Title>Accounts of chemical research</Title>
<ISOAbbreviation>Acc. Chem. Res.</ISOAbbreviation>
</Journal>
<ArticleTitle>Chemical construction and structural permutation of potent cytotoxin polytheonamide B: discovery of artificial peptides with distinct functions.</ArticleTitle>
<Pagination><MedlinePgn>1567-78</MedlinePgn>
</Pagination>
<ELocationID EIdType="doi" ValidYN="Y">10.1021/ar300315p</ELocationID>
<Abstract><AbstractText>Polytheonamide B (1), isolated from the marine sponge Theonella swinhoei, is a posttranslationally modified ribosomal peptide (MW 5030 Da) that displays extraordinary cytotoxicity. Among its 48 amino acid residues, this peptide includes a variety D- and L-amino acids that do not occur in proteins, and the chiralities of these amino acids alternate in sequence. These structural features induce the formation of a stable β6.3-helix, giving rise to a tubular structure of over 4 nm in length. In the biological setting, this fold is believed to transport cations across the lipid bilayer through a pore, thereby acting as an ion channel. In this Account, we discuss the construction and structural permutations of this potent cytotoxin. First we describe the 161-step chemical construction of this unusual peptide 1. By developing a synthetic route to 1, we established the chemical basis for subsequent SAR studies to pinpoint the proteinogenic and nonproteinogenic building blocks within the molecule that confer its toxicity and channel function. Using fully synthetic 1, we generated seven analogues with point mutations, and studies of their activity revealed the importance of the N-terminal moiety. Next, we simplified the structure of 1 by substituting six amino acid residues of 1 to design a more synthetically accessible analogue 9. This dansylated polytheonamide mimic 9 was synthesized in 127 total steps, and we evaluated its function to show that it can emulate the toxic and ion channel activities of 1 despite its multiple structural modifications. Finally, we applied a highly automated synthetic route to 48-mer 9 to generate 13 substructures of 27-39-mers. The 37-mer 12 exhibited nanomolar level toxicity through a potentially distinct mode of action from 1 and 9. The SAR studies of polytheonamide B and the 21 artificial analogues have deepened our understanding of the precise structural requirements for the biological functions of 1. They have also led to the discovery of artificial molecules with various toxicities and channel functions. These achievements demonstrate the benefits of total synthesis and the importance of efficient construction of complex molecules. The knowledge accumulated through these studies will be useful for the rational design of new tailor-made channel peptides and cytotoxic molecules with desired functions.</AbstractText>
</Abstract>
<AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Itoh</LastName>
<ForeName>Hiroaki</ForeName>
<Initials>H</Initials>
<AffiliationInfo><Affiliation>Graduate School of Pharmaceutical Sciences, The University of Tokyo, Hongo, Bunkyo-ku, Tokyo 113-0033, Japan.</Affiliation>
</AffiliationInfo>
</Author>
<Author ValidYN="Y"><LastName>Inoue</LastName>
<ForeName>Masayuki</ForeName>
<Initials>M</Initials>
</Author>
</AuthorList>
<Language>eng</Language>
<PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType>
<PublicationType UI="D013485">Research Support, Non-U.S. Gov't</PublicationType>
<PublicationType UI="D016454">Review</PublicationType>
</PublicationTypeList>
<ArticleDate DateType="Electronic"><Year>2013</Year>
<Month>03</Month>
<Day>14</Day>
</ArticleDate>
</Article>
<MedlineJournalInfo><Country>United States</Country>
<MedlineTA>Acc Chem Res</MedlineTA>
<NlmUniqueID>0157313</NlmUniqueID>
<ISSNLinking>0001-4842</ISSNLinking>
</MedlineJournalInfo>
<ChemicalList><Chemical><RegistryNumber>0</RegistryNumber>
<NameOfSubstance UI="D003603">Cytotoxins</NameOfSubstance>
</Chemical>
<Chemical><RegistryNumber>0</RegistryNumber>
<NameOfSubstance UI="D047908">Intracellular Signaling Peptides and Proteins</NameOfSubstance>
</Chemical>
<Chemical><RegistryNumber>0</RegistryNumber>
<NameOfSubstance UI="D057786">Peptidomimetics</NameOfSubstance>
</Chemical>
<Chemical><RegistryNumber>0</RegistryNumber>
<NameOfSubstance UI="D011506">Proteins</NameOfSubstance>
</Chemical>
<Chemical><RegistryNumber>0</RegistryNumber>
<NameOfSubstance UI="C111717">polytheonamide B</NameOfSubstance>
</Chemical>
</ChemicalList>
<CitationSubset>IM</CitationSubset>
<MeshHeadingList><MeshHeading><DescriptorName UI="D003603" MajorTopicYN="N">Cytotoxins</DescriptorName>
<QualifierName UI="Q000138" MajorTopicYN="N">chemical synthesis</QualifierName>
<QualifierName UI="Q000737" MajorTopicYN="Y">chemistry</QualifierName>
<QualifierName UI="Q000494" MajorTopicYN="Y">pharmacology</QualifierName>
</MeshHeading>
<MeshHeading><DescriptorName UI="D055808" MajorTopicYN="N">Drug Discovery</DescriptorName>
<QualifierName UI="Q000379" MajorTopicYN="Y">methods</QualifierName>
</MeshHeading>
<MeshHeading><DescriptorName UI="D047908" MajorTopicYN="N">Intracellular Signaling Peptides and Proteins</DescriptorName>
</MeshHeading>
<MeshHeading><DescriptorName UI="D057786" MajorTopicYN="N">Peptidomimetics</DescriptorName>
<QualifierName UI="Q000138" MajorTopicYN="N">chemical synthesis</QualifierName>
<QualifierName UI="Q000737" MajorTopicYN="Y">chemistry</QualifierName>
<QualifierName UI="Q000494" MajorTopicYN="Y">pharmacology</QualifierName>
</MeshHeading>
<MeshHeading><DescriptorName UI="D017354" MajorTopicYN="N">Point Mutation</DescriptorName>
</MeshHeading>
<MeshHeading><DescriptorName UI="D011506" MajorTopicYN="N">Proteins</DescriptorName>
<QualifierName UI="Q000138" MajorTopicYN="N">chemical synthesis</QualifierName>
<QualifierName UI="Q000737" MajorTopicYN="Y">chemistry</QualifierName>
<QualifierName UI="Q000235" MajorTopicYN="N">genetics</QualifierName>
<QualifierName UI="Q000378" MajorTopicYN="Y">metabolism</QualifierName>
</MeshHeading>
</MeshHeadingList>
</MedlineCitation>
<PubmedData><History><PubMedPubDate PubStatus="entrez"><Year>2013</Year>
<Month>3</Month>
<Day>16</Day>
<Hour>6</Hour>
<Minute>0</Minute>
</PubMedPubDate>
<PubMedPubDate PubStatus="pubmed"><Year>2013</Year>
<Month>3</Month>
<Day>16</Day>
<Hour>6</Hour>
<Minute>0</Minute>
</PubMedPubDate>
<PubMedPubDate PubStatus="medline"><Year>2014</Year>
<Month>1</Month>
<Day>28</Day>
<Hour>6</Hour>
<Minute>0</Minute>
</PubMedPubDate>
</History>
<PublicationStatus>ppublish</PublicationStatus>
<ArticleIdList><ArticleId IdType="pubmed">23488446</ArticleId>
<ArticleId IdType="doi">10.1021/ar300315p</ArticleId>
</ArticleIdList>
</PubmedData>
</pubmed>
<affiliations><list><country><li>Japon</li>
</country>
<region><li>Région de Kantō</li>
</region>
<settlement><li>Tokyo</li>
</settlement>
<orgName><li>Université de Tokyo</li>
</orgName>
</list>
<tree><noCountry><name sortKey="Inoue, Masayuki" sort="Inoue, Masayuki" uniqKey="Inoue M" first="Masayuki" last="Inoue">Masayuki Inoue</name>
</noCountry>
<country name="Japon"><region name="Région de Kantō"><name sortKey="Itoh, Hiroaki" sort="Itoh, Hiroaki" uniqKey="Itoh H" first="Hiroaki" last="Itoh">Hiroaki Itoh</name>
</region>
</country>
</tree>
</affiliations>
</record>
Pour manipuler ce document sous Unix (Dilib)
EXPLOR_STEP=$WICRI_ROOT/Sante/explor/MersV1/Data/Ncbi/Merge
HfdSelect -h $EXPLOR_STEP/biblio.hfd -nk 000A32 | SxmlIndent | more
Ou
HfdSelect -h $EXPLOR_AREA/Data/Ncbi/Merge/biblio.hfd -nk 000A32 | SxmlIndent | more
Pour mettre un lien sur cette page dans le réseau Wicri
{{Explor lien |wiki= Sante |area= MersV1 |flux= Ncbi |étape= Merge |type= RBID |clé= pubmed:23488446 |texte= Chemical construction and structural permutation of potent cytotoxin polytheonamide B: discovery of artificial peptides with distinct functions. }}
Pour générer des pages wiki
HfdIndexSelect -h $EXPLOR_AREA/Data/Ncbi/Merge/RBID.i -Sk "pubmed:23488446" \ | HfdSelect -Kh $EXPLOR_AREA/Data/Ncbi/Merge/biblio.hfd \ | NlmPubMed2Wicri -a MersV1
![]() | This area was generated with Dilib version V0.6.33. | ![]() |